Crossmark

Design, synthesis, and in vitro evaluation of novel 1,3,4-oxadiazolecarbamothioate derivatives of Rivastigmine as selective inhibitors of BuChE

Published Online: 2019-12-16

Published Print: 2020-03

Authors

Fallah, Akram

Mohanazadeh, Farajollah

Safavi, Maliheh
License Information

Text and Data Mining valid from 2019-12-16

Version of Record valid from 2019-12-16
More Information

Article History

Received: 14 August 2019

Accepted: 8 November 2019

First Online: 16 December 2019

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current